Bayer testing Pharmanetics technology

Bayer (Pittsburgh, Penn.) and PHAR will develop a point-of-care test to monitor the effect of platelet inhibitors, specifically focusing on GPIIb/IIIa inhibitors. PHAR will modify its dry chemistry te...